Zymeworks Inc. (NYSE:ZYME)

Stock Price: $9.70
-0.12 (-1.22%)
Updated Feb 7, 2023 09:00 PM GMT+0000
Featured app
eToro
Invest now
<p>79% of retail CFD accounts lose money</p>
Overview
Financials
Statistics
Profile
Chart
Market Cap 611.13M
Revenue 31.62M
Gross Profit 31.62M
Shares Out 63M
EPS (ttm) -4.06
PE Ratio -2.5789
Forward PE 0.0000
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Feb 7
Last Price $9.70
Previous Close $9.82
Change ($) -0.12
Change (%) -1.22%
Day's Open 9.8
Day's Range Market Closed
Day's Volume 484.43K
52 Week Range 4.11 - 10.8

About Zymeworks Inc.

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks' suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.

Zymeworks' lead clinical candidate, zanidatamab (ZW25), is a novel Azymetric™ bispecific antibody which has been granted Breakthrough Therapy designation by the FDA and is currently enrolling in a pivotal clinical trial for refractory HER2-amplified biliary tract cancer (HERIZON-BTC-01) as well as several Phase 2 clinical trials for HER2-expressing gastroesophageal and breast cancers. Zymeworks' second clinical candidate, ZW49, is a novel bispecific HER2-targeting antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks' proprietary ZymeLink™ linker and cytotoxin.

Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies.

News

Quick info

Country
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
458
Address
540-1385 West 8Th Avenue
Vancouver
British Columbia
V6H 3V9
Phone
16046781388
Ticker Symbol
ZYME
Reporting Currency
USD